Correction to: Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK.
Susan E Bromley;
Anthony Matthews;
Liam Smeeth 
;
Susannah Stanway;
Krishnan Bhaskaran ;
(2019)
Correction to: Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK.
JOURNAL OF CANCER SURVIVORSHIP, 13 (6).
910-.
ISSN 1932-2259
DOI: 10.1007/s11764-019-00806-5
;
Susannah Stanway;
Krishnan Bhaskaran ;
(2019)
Correction to: Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK.
JOURNAL OF CANCER SURVIVORSHIP, 13 (6).
910-.
ISSN 1932-2259
DOI: 10.1007/s11764-019-00806-5
The article Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK, written by Susan E. Bromley, was originally published electronically on the publisher's internet portal.
-
picture_as_pdf - 11764_2019_Article_782.pdf
-
subject - Published Version
-
- Available under Creative Commons: NC-ND 3.0
Downloads